Stay updated on Biomarker Analysis in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Biomarker Analysis in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Analysis in Urothelial Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The new screenshot shows only minor layout and formatting changes; core study content (eligibility criteria, endpoints, and Pembrolizumab treatment details) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T13:12:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:15:58.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:38:36.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. Back to Top link removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:45:39.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T07:39:41.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several key medical topics and terms related to pembrolizumab and urological diseases have been removed.
    Difference
    3%
    Check dated 2025-08-31T00:52:27.000Z thumbnail image

Stay in the know with updates to Biomarker Analysis in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Analysis in Urothelial Cancer Clinical Trial page.